Carregant...

Attenuating Smac Mimetic Compound 3-induced NF-κB Activation by Luteolin Leads to Synergistic Cytotoxicity in Cancer Cells

Smac mimetics are potential anticancer therapeutics selectively killing cancer cells through autocrine tumor necrosis factor (TNF)-mediated apoptosis pathway. Our recent study reveal that the Smac mimetic compound 3 (SMC3)-activated NF-κB protects cancer cells against apoptosis, thus blunting SMC3’s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Bai, Lang, Chen, Wenjie, Wang, Xia, Ju, Wei, Xu, Shanling, Lin, Yong
Format: Artigo
Idioma:Inglês
Publicat: 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071149/
https://ncbi.nlm.nih.gov/pubmed/19739098
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcb.22346
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!